Back
Chemed 10K Form
Sell
50
CHE
Chemed
Last Price:
565.09
Seasonality Move:
6.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-29 | 10Q | CHE/Chemed Quarterly |
| 2024-02-29 | 10K | CHE/Chemed Annual |
| 2023-10-27 | 10Q | CHE/Chemed Quarterly |
| 2023-07-28 | 10Q | CHE/Chemed Quarterly |
| 2023-04-28 | 10Q | CHE/Chemed Quarterly |
| 2023-02-27 | 10K | CHE/Chemed Annual |
Receive CHE News And Ratings
See the #1 stock for the next 7 days that we like better than CHE
CHE Financial Statistics
Sales & Book Value
| Annual Sales: | $2.26B |
|---|---|
| Cash Flow: | $76.97M |
| Price / Cash Flow: | 27.6 |
| Annual Sales: | $82.48 |
| Price / Book: | 6.86 |
Profitability
| EPS (TTM): | 19.79000 |
|---|---|
| Net Income (TTM): | $301.73M |
| Gross Margin: | $798.82M |
| Return on Equity: | 26.22% |
| Return on Assets: | 17.83% |
Chemed Earnings Forecast
Key Chemed Financial Ratios
- The Gross Profit Margin over the past 40 years for CHE is 35.28%.
- The Selling, General & Administrative Expenses for CHE have been equal to 17.45% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 1.14% of Operating Income.
- The Net Earning history of CHE is 12.03% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 26 years.
Chemed Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | CHE |
| CUSIP: | 16359R |
| Website: | chemed.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.85 |
| Quick Ratio: | 1.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 31.54 |
|---|---|
| Forward P/E Ratio: | 22.72 |